Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
SURG's Cash to Debt is ranked higher than
93% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. SURG: No Debt )
SURG' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.75
SURG's Equity to Asset is ranked higher than
79% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SURG: 0.75 )
SURG' s 10-Year Equity to Asset Range
Min: 0.57   Max: 0.98
Current: 0.75

0.57
0.98
Interest Coverage No Debt
SURG's Interest Coverage is ranked higher than
73% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 235.10 vs. SURG: No Debt )
SURG' s 10-Year Interest Coverage Range
Min: 1.56   Max: 9999.99
Current: No Debt

1.56
9999.99
F-Score: 6
Z-Score: 5.24
M-Score: -3.00
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.60
SURG's Operating margin (%) is ranked higher than
76% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. SURG: 6.60 )
SURG' s 10-Year Operating margin (%) Range
Min: -8.11   Max: 15
Current: 6.6

-8.11
15
Net-margin (%) 4.40
SURG's Net-margin (%) is ranked higher than
75% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. SURG: 4.40 )
SURG' s 10-Year Net-margin (%) Range
Min: -7.41   Max: 11.01
Current: 4.4

-7.41
11.01
ROE (%) 4.59
SURG's ROE (%) is ranked higher than
72% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. SURG: 4.59 )
SURG' s 10-Year ROE (%) Range
Min: -2.53   Max: 16.86
Current: 4.59

-2.53
16.86
ROA (%) 3.44
SURG's ROA (%) is ranked higher than
75% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. SURG: 3.44 )
SURG' s 10-Year ROA (%) Range
Min: -2.44   Max: 11.03
Current: 3.44

-2.44
11.03
ROC (Joel Greenblatt) (%) 12.82
SURG's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. SURG: 12.82 )
SURG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -13.95   Max: 40.77
Current: 12.82

-13.95
40.77
Revenue Growth (3Y)(%) 4.70
SURG's Revenue Growth (3Y)(%) is ranked higher than
74% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. SURG: 4.70 )
SURG' s 10-Year Revenue Growth (3Y)(%) Range
Min: -2.6   Max: 50.6
Current: 4.7

-2.6
50.6
EBITDA Growth (3Y)(%) -13.40
SURG's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. SURG: -13.40 )
SURG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 115.4
Current: -13.4

0
115.4
EPS Growth (3Y)(%) -19.50
SURG's EPS Growth (3Y)(%) is ranked higher than
66% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. SURG: -19.50 )
SURG' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 122.4
Current: -19.5

0
122.4
» SURG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

SURG Guru Trades in Q4 2013

Jim Simons 50,701 sh (+299.22%)
Chuck Royce 981,274 sh (+81.86%)
» More
Q1 2014

SURG Guru Trades in Q1 2014

Chuck Royce 1,491,274 sh (+51.97%)
Jim Simons 52,400 sh (+3.35%)
» More
Q2 2014

SURG Guru Trades in Q2 2014

Jim Simons 79,500 sh (+51.72%)
Chuck Royce 1,531,149 sh (+2.67%)
» More
Q3 2014

SURG Guru Trades in Q3 2014

Jim Simons 153,400 sh (+92.96%)
Chuck Royce 1,531,149 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with SURG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 38.80
SURG's P/E(ttm) is ranked higher than
80% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 84.60 vs. SURG: 38.80 )
SURG' s 10-Year P/E(ttm) Range
Min: 5.03   Max: 335.63
Current: 38.8

5.03
335.63
P/B 1.76
SURG's P/B is ranked higher than
85% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. SURG: 1.76 )
SURG' s 10-Year P/B Range
Min: 0.49   Max: 9.59
Current: 1.76

0.49
9.59
P/S 1.72
SURG's P/S is ranked higher than
82% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. SURG: 1.72 )
SURG' s 10-Year P/S Range
Min: 0.34   Max: 7.18
Current: 1.72

0.34
7.18
PFCF 13.64
SURG's PFCF is ranked higher than
95% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SURG: 13.64 )
SURG' s 10-Year PFCF Range
Min: 1.6   Max: 99999999.99
Current: 13.64

1.6
99999999.99
EV-to-EBIT 21.56
SURG's EV-to-EBIT is ranked higher than
84% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 61.55 vs. SURG: 21.56 )
SURG' s 10-Year EV-to-EBIT Range
Min: -796.9   Max: 153.4
Current: 21.56

-796.9
153.4
Shiller P/E 26.23
SURG's Shiller P/E is ranked higher than
93% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SURG: 26.23 )
SURG' s 10-Year Shiller P/E Range
Min: 8   Max: 255
Current: 26.23

8
255
Current Ratio 5.71
SURG's Current Ratio is ranked higher than
87% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. SURG: 5.71 )
SURG' s 10-Year Current Ratio Range
Min: 1.73   Max: 30
Current: 5.71

1.73
30
Quick Ratio 4.01
SURG's Quick Ratio is ranked higher than
84% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. SURG: 4.01 )
SURG' s 10-Year Quick Ratio Range
Min: 0.68   Max: 14
Current: 4.01

0.68
14

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 7.50
SURG's Price/Net Current Asset Value is ranked higher than
90% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SURG: 7.50 )
SURG' s 10-Year Price/Net Current Asset Value Range
Min: 3.53   Max: 127.5
Current: 7.5

3.53
127.5
Price/Tangible Book 2.93
SURG's Price/Tangible Book is ranked higher than
83% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 6.92 vs. SURG: 2.93 )
SURG' s 10-Year Price/Tangible Book Range
Min: 1.84   Max: 19.65
Current: 2.93

1.84
19.65
Price/DCF (Projected) 1.03
SURG's Price/DCF (Projected) is ranked higher than
96% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SURG: 1.03 )
SURG' s 10-Year Price/DCF (Projected) Range
Min: 0.73   Max: 23.44
Current: 1.03

0.73
23.44
Price/Median PS Value 0.87
SURG's Price/Median PS Value is ranked higher than
85% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. SURG: 0.87 )
SURG' s 10-Year Price/Median PS Value Range
Min: 0.23   Max: 4.97
Current: 0.87

0.23
4.97
Price/Graham Number 2.26
SURG's Price/Graham Number is ranked higher than
86% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SURG: 2.26 )
SURG' s 10-Year Price/Graham Number Range
Min: 0.82   Max: 14.29
Current: 2.26

0.82
14.29
Earnings Yield (Greenblatt) 4.60
SURG's Earnings Yield (Greenblatt) is ranked higher than
84% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SURG: 4.60 )
SURG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 18.4
Current: 4.6

0.7
18.4
Forward Rate of Return (Yacktman) -5.71
SURG's Forward Rate of Return (Yacktman) is ranked higher than
65% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.52 vs. SURG: -5.71 )
SURG' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -9.6   Max: 1024
Current: -5.71

-9.6
1024

Analyst Estimate

Jul15 Jul16
Revenue(Mil) 74 85
EPS($) 0.16 0.23
EPS without NRI($) 0.16 0.23

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Synergetics USA Inc is a Delaware corporation incorporated on June 2, 2005 in connection with the reverse merger of Synergetics, Inc. and Valley Forge Scientific Corp. The Company is a supplier of precision surgical devices. It develops, manufactures, and markets disposable and durable equipment for use in ophthalmologic, neurosurgical, and other microsurgical applications. The Company's product lines focus upon precision engineered, disposable and reusable devices, procedural kits and the delivery of various energy modalities for the performance of surgery, including: laser energy, ultrasonic energy, radio frequency energy for electrosurgery and lesion generation and visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. It's ophthalmic and vitreoretinal surgical devices and equipment compete against manufacturers of similar products, including those sold by its major competitors, Alcon, Bausch & Lomb, Inc., Dutch Ophthalmic Research Center and Iridex. The Company is subject to macro-economic fluctuations in the United States, the countries of Europe and the economies of other countries throughout the world. Medical device companies are subject to rigorous regulation, including by the FDA and numerous other federal, state and foreign governmental authorities.
» More Articles for SURG

Headlines

Articles On GuruFocus.com
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2015 Results Dec 01 2014 
Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2014 Results Oct 15 2014 
Synergetics USA: A Growth Story Amidst an Aging Population Aug 30 2012 
Synergetics Up 30% after Approval for Eye Surgery Device Jun 28 2012 
Synergetics USA Inc. (SURG) EVP & COO Kurt W Jr Gampp sells 43,000 Shares Mar 15 2011 
Weekly CFO Buys Highlight: CNLG, SIFID, FUL, SURG, TYL Jan 15 2011 
Synergetics USA Inc. (SURG) President and CEO David M Hable sells 17,000 Shares Jan 07 2011 
Weekly CFO Buys Highlight: COIN, INTC, SURG, IBCA, AUMN Oct 24 2010 
Synergetics USA, Inc. Announces 3 Month Extension of Current Agreements with Codman & Shurtleff, Inc Jan 07 2009 


More From Other Websites
SYNERGETICS USA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Dec 17 2014
SYNERGETICS USA INC Financials Dec 17 2014
Synergetics USA (SURG) Jumps: Stock Adds 9.1% in Session Dec 15 2014
10-Q for Synergetics USA, Inc. Dec 12 2014
SYNERGETICS USA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 12 2014
SYNERGETICS USA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Dec 10 2014
Synergetics posts 1Q profit Dec 10 2014
Synergetics posts 1Q profit Dec 10 2014
SYNERGETICS USA INC Files SEC form 10-Q, Quarterly Report Dec 10 2014
Synergetics Reports First Quarter of Fiscal Year 2015 Results Dec 10 2014
Synergetics Acquires U.K.-Based Manufacturer Sterimedix Ltd. Dec 10 2014
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2015 Results Dec 01 2014
SYNERGETICS USA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 12 2014
SYNERGETICS USA INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 30 2014
Synergetics posts 4Q profit Oct 14 2014
Synergetics posts 4Q profit Oct 14 2014
SYNERGETICS USA INC Files SEC form 8-K, Results of Operations and Financial Condition Oct 14 2014
Synergetics Reports Fourth Quarter and Fiscal Year 2014 Results Oct 14 2014
SYNERGETICS USA INC Files SEC form 10-K, Annual Report Oct 14 2014
Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2014 Results Oct 01 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK